retatrutide approved Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation clinicalresearch #retatrutide #clinicaltrials #patientsafety #obesity
Description
Treatment selection depends on individual factors including weight loss goals, tolerability preferences, and metabolic markers rather than diabetes diagnosis
Roches AI factory with its 3,500 GPUs and digital twins is propelling that transformation forward

In one meta-analysis PIO was found to be the most effective drug for the treatment of NASH followed by Roux-en-Y gastric bypass procedure [53]

The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse

The drug manages the condition while you take it

Mounjaro became available through primary care in June 2025 as part of a phased rollout, initially for people with a BMI of 40 or above and at least four weight-related health conditions
